Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank Pembangunan Daerah Banten Tbk. (BEKS) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Bank Pembangunan Daerah Banten Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Bank Pembangunan Daerah Banten Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Pembangunan Daerah Banten Tbk. trades at Rp23 (market cap 1.18T, 1.57M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 164.65B, 46K 24h volume). The key difference: Bank Pembangunan Daerah Banten Tbk. is far larger — about 7.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Bank Pembangunan Daerah Banten Tbk. is more actively traded (1.57M versus 46K). Which is the better fit depends on your goals.

BEKSOBAT
Market Cap
1.18T164.65B
Volume
1.57M46K
Lot
15.7K460
Turnover
36.81M11.1M
Average Price
23.45241.33
Value
36.81M11.1M
Indicative Equilibrium Price
23238
Indicative Equilibrium Volume
2.53K100

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BEKS
View details
OBAT
View details

About Bank Pembangunan Daerah Banten Tbk.

PT Bank Pembangunan Daerah Banten Tbk formerly PT Bank Pundi Indonesia, Tbk (“the Bank”) was established on September 11, 1992. Based on the Bank’s Articles of Association’s amendment by Deed No. 104 dated June 30, 2010 of Fathiah Helmi, S.H., Notary in Jakarta, “PT Bank Eksekutif Internasional Tbk” has changed its name to “PT Bank Pundi Indonesia Tbk”. Based on the Bank’s Articles of Association’s amendment by Deed No. 36 dated June 14, 2016 of Fathiah Helmi, S.H., Notary in Jakarta, “PT Bank Pundi Indonesia Tbk” has changed its name to “PT Bank Pembangunan Daerah Banten Tbk”.

Read more on BEKS

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT